Cleared Traditional

K923970 - INTEGRITY 2

K923970 is an FDA 510(k) clearance for INTEGRITY 2, manufactured by Medrotech Corp.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 285-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
May 1993
Decision
285d
Days
Class 2
Risk

K923970 is an FDA 510(k) clearance for the INTEGRITY 2. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Medrotech Corp. (Riviera Beach, US). The FDA issued a Cleared decision on May 18, 1993 after a review of 285 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K923970

510(k) Number K923970 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 06, 1992
Decision Date May 18, 1993
Days to Decision 285 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
136d slower than avg
Panel avg: 149d · This submission: 285d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K923970.
COM-TENS (SINGLE MODE)
K931570 · Ems Dist. · Jun 1993
MAXIMA I
K931424 · Staodyne, Inc. · Jun 1993
MICROCARE(TM)
K926326 · American Imex · Jun 1993
K-STIM CLEAR
K922202 · Katecho, Inc. · May 1993
STAODYN MAXIMA III
K930865 · Staodyne, Inc. · May 1993
COMFORTRON
K925821 · M. D. Supply, Inc. · May 1993